Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,372 | 481 | 53.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,493 | 5 | 28.5% |
| Travel and Lodging | $2,103 | 7 | 10.9% |
| Education | $1,169 | 51 | 6.1% |
| Gift | $120.42 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $8,164 | 34 | $0 (2024) |
| Astellas Pharma US Inc | $2,066 | 105 | $0 (2024) |
| PROCEPT BioRobotics Corporation | $1,080 | 7 | $0 (2024) |
| Janssen Biotech, Inc. | $882.56 | 44 | $0 (2024) |
| ABBVIE INC. | $632.67 | 42 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $569.62 | 24 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $500.81 | 22 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $490.27 | 26 | $0 (2024) |
| TOLMAR Pharmaceuticals, Inc. | $489.42 | 43 | $0 (2022) |
| PFIZER INC. | $442.23 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,957 | 85 | ABBVIE INC. ($226.98) |
| 2023 | $2,064 | 92 | Astellas Pharma US Inc ($498.02) |
| 2022 | $2,767 | 111 | PROCEPT BioRobotics Corporation ($1,022) |
| 2021 | $2,482 | 51 | BOSTON SCIENTIFIC CORPORATION ($1,760) |
| 2020 | $1,541 | 26 | Boston Scientific Corporation ($960.00) |
| 2019 | $1,261 | 58 | Astellas Pharma US Inc ($319.56) |
| 2018 | $4,724 | 79 | BOSTON SCIENTIFIC CORPORATION ($3,436) |
| 2017 | $2,461 | 43 | BOSTON SCIENTIFIC CORPORATION ($1,716) |
All Payment Transactions
545 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: UROLOGY | ||||||
| 12/18/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $31.07 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/04/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $13.92 | General |
| Category: Prostate cancer | ||||||
| 12/02/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Oncology | ||||||
| 11/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $25.16 | General |
| Category: HORMONE THERAPY | ||||||
| 11/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/06/2024 | Boston Scientific Corporation | LithoVue (Device) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: LithoVue_URO | ||||||
| 10/31/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $27.53 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/30/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $14.28 | General |
| Category: Prostate cancer | ||||||
| 10/29/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/29/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $1.33 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/25/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: ONCOLOGY | ||||||
| 10/25/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $17.85 | General |
| Category: UROLOGY | ||||||
| 10/11/2024 | KOELIS Inc. | Trinity (Device) | Food and Beverage | In-kind items and services | $53.56 | General |
| Category: Urology | ||||||
| 10/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Oncology | ||||||
| 10/03/2024 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Genetic Disease | ||||||
| 09/24/2024 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $35.07 | General |
| 09/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $2.20 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/19/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: ONCOLOGY | ||||||
| 09/17/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: ONCOLOGY | ||||||
| 09/12/2024 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: rezum_URO | ||||||
| 08/29/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 39 | 3,507 | 10,571 | $725,988 | $258,125 |
| 2022 | 39 | 3,295 | 10,744 | $737,242 | $264,874 |
| 2021 | 38 | 3,264 | 10,005 | $648,556 | $239,791 |
| 2020 | 41 | 3,155 | 11,258 | $593,175 | $216,044 |
All Medicare Procedures & Services
157 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 371 | 500 | $129,563 | $44,553 | 34.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 520 | 702 | $128,538 | $43,249 | 33.6% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 40 | 271 | $102,167 | $36,398 | 35.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 176 | 176 | $59,172 | $19,243 | 32.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 85 | 100 | $49,476 | $17,746 | 35.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 16 | 966 | $44,436 | $17,727 | 39.9% |
| 0421T | Waterjet destruction of prostrate accessed through the urethra | Facility | 2023 | 20 | 20 | $32,170 | $10,604 | 33.0% |
| 52648 | Complete laser vaporization of prostate including control of bleeding using an endoscope | Facility | 2023 | 19 | 19 | $26,201 | $10,061 | 38.4% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 54 | 55 | $15,523 | $5,631 | 36.3% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 205 | 277 | $10,249 | $4,992 | 48.7% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 14 | 15 | $12,232 | $4,903 | 40.1% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 24 | 24 | $11,784 | $4,514 | 38.3% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 756 | 1,139 | $6,834 | $3,540 | 51.8% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 16 | 17 | $9,172 | $3,305 | 36.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 335 | 421 | $9,262 | $3,120 | 33.7% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 12 | 12 | $7,831 | $2,984 | 38.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 256 | 359 | $5,927 | $2,967 | 50.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 29 | 29 | $7,569 | $2,956 | 39.1% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 40 | 87 | $6,090 | $2,099 | 34.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 27 | 27 | $6,108 | $2,008 | 32.9% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 16 | 17 | $5,286 | $1,967 | 37.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 14 | $5,068 | $1,959 | 38.6% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 21 | 27 | $4,216 | $1,601 | 38.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 22 | 35 | $3,500 | $1,365 | 39.0% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 13 | 13 | $3,978 | $1,254 | 31.5% |
About Dr. Michael Gross, M.D
Dr. Michael Gross, M.D is a Urology healthcare provider based in Plano, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447207493.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Gross, M.D has received a total of $19,257 in payments from pharmaceutical and medical device companies, with $1,957 received in 2024. These payments were reported across 545 transactions from 65 companies. The most common payment nature is "Food and Beverage" ($10,372).
As a Medicare-enrolled provider, Gross has provided services to 13,221 Medicare beneficiaries, totaling 42,578 services with total Medicare billing of $978,834. Data is available for 4 years (2020–2023), covering 157 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Plano, TX
- Active Since 05/27/2006
- Last Updated 01/31/2017
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1447207493
Products in Payments
- GREENLIGHT (Device) $3,409
- GENERAL BPH (Device) $2,853
- AQUABEAM ROBOTIC SYSTEM (Device) $1,043
- GENERAL - BPH (Device) $1,028
- XTANDI (Drug) $953.53
- ORGOVYX (Drug) $597.13
- MYRBETRIQ (Drug) $552.24
- PROVENGE (Drug) $537.84
- ELIGARD (Drug) $532.78
- Myrbetriq (Drug) $458.19
- Nubeqa (Drug) $434.60
- ERLEADA (Drug) $416.75
- BOTOX (Biological) $395.61
- GEMTESA (Drug) $344.17
- LUPRON DEPOT (Drug) $253.39
- ZYTIGA (Drug) $222.87
- Erleada (Drug) $214.36
- XIAFLEX (Biological) $201.50
- LITHOVUE (Device) $190.02
- KEYTRUDA (Biological) $175.78
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Plano
Dr. Jeffrey Hassell, M.d, M.D
Urology — Payments: $29,670
Michael Wierschem, M.d, M.D
Urology — Payments: $16,919
Joseph Scales, Md, MD
Urology — Payments: $8,844
Dr. Mark Allen, M.d, M.D
Urology — Payments: $8,628
Mr. Stephen Lieman, M.d, M.D
Urology — Payments: $8,574
Meredith Lightfoot, M.d, M.D
Urology — Payments: $8,084